Ten years after receiving a treatment that modifies a patient's own immune cells to attack cancer, two patients who had a form of blood cancer show no signs of the disease, researchers report Wednesday.
Why it matters: The patients' remissions hint at how long the effects of CAR-T therapy — a promising but currently very costly treatment— may persist in some people.
